This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ paroxetine hydrochloride,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Depression: Paroxetine hydrochloride is primarily prescribed for the treatment of depression. It works by increasing the levels of serotonin, a neurotransmitter, in the brain, which helps improve mood and alleviate depressive symptoms.

  2. Anxiety Disorders: Paroxetine hydrochloride is also used to treat various anxiety disorders, including generalized anxiety disorder (GAD), social anxiety disorder (social phobia), panic disorder, and obsessive-compulsive disorder (OCD).

  3. Premenstrual Dysphoric Disorder (PMDD): Paroxetine hydrochloride may be prescribed to manage symptoms of PMDD, a severe form of premenstrual syndrome (PMS), such as mood swings, irritability, and physical symptoms.

  4. Post-Traumatic Stress Disorder (PTSD): Paroxetine hydrochloride is sometimes used off-label to treat symptoms of PTSD, such as intrusive thoughts, flashbacks, nightmares, and hypervigilance.

  5. Other Conditions: Paroxetine hydrochloride may also be prescribed off-label for conditions such as eating disorders, certain types of chronic pain, and menopausal symptoms.

  6. Side Effects: Common side effects of paroxetine hydrochloride may include nausea, drowsiness, dry mouth, constipation, sweating, sexual dysfunction, and weight changes. These side effects are usually mild and may diminish over time. However, some individuals may experience more severe side effects or allergic reactions, such as rash, swelling, or difficulty breathing, which require immediate medical attention.

  7. Withdrawal Symptoms: Discontinuing paroxetine hydrochloride abruptly or too rapidly may lead to withdrawal symptoms, commonly referred to as "discontinuation syndrome." These symptoms may include dizziness, headache, nausea, fatigue, irritability, and flu-like symptoms. It's essential to taper off the medication gradually under the supervision of a healthcare professional to minimize withdrawal effects.

  8. Suicidal Thoughts and Behavior: Like other antidepressants, paroxetine hydrochloride may increase the risk of suicidal thoughts or behaviors, especially in children, adolescents, and young adults. Close monitoring is necessary, particularly when starting the medication or adjusting the dosage.

  9. Serotonin Syndrome: In rare cases, the use of paroxetine hydrochloride may lead to serotonin syndrome, a potentially life-threatening condition characterized by dangerously high levels of serotonin in the brain. Symptoms may include agitation, hallucinations, rapid heartbeat, fever, excessive sweating, shivering, muscle stiffness, tremors, and loss of coordination. Seek immediate medical attention if you experience any of these symptoms.

  10. Drug Interactions: Paroxetine hydrochloride can interact with other medications, including other antidepressants, certain pain medications, migraine drugs, blood thinners, and herbal supplements like St. John's wort. It's crucial to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

  11. Pregnancy and Breastfeeding: The use of paroxetine hydrochloride during pregnancy may be associated with an increased risk of certain birth defects and complications, particularly if used during the first trimester. It may also pass into breast milk and potentially affect the nursing infant. If you are pregnant or breastfeeding, discuss the risks and benefits of using paroxetine hydrochloride with your healthcare provider.

  12. Liver and Kidney Function: Paroxetine hydrochloride should be used with caution in individuals with impaired liver or kidney function, as the dosage may need to be adjusted based on the severity of impairment.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of paroxetine hydrochloride,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Bifidobacterium longum Reduces
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by paroxetine hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
0 1 Cryptococcaceae family Decreases
0 1 Akkermansiaceae family Decreases
1 0 Cryptococcus genus Decreases
0 1 Agathobacter genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 Segatella genus Decreases
0 1 Escherichia genus Decreases
0 1 Staphylococcus genus Decreases
0 1 Collinsella genus Decreases
0 1 Clostridioides genus Decreases
0 1 Shigella genus Decreases
1 0 Akkermansia genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Lachnospira genus Decreases
0 1 Leyella genus Decreases
0 1 Coprococcus genus Decreases
0 1 Blautia genus Decreases
0 1 Roseburia genus Decreases
0 1 Eggerthella genus Decreases
0 1 Thomasclavelia genus Decreases
0 1 Bacteroides genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Lacrimispora genus Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 unclassified Cryptococcus (in: basidiomycete fungi) no rank Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Agathobacter rectalis species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
1 0 Segatella copri species Decreases
1 0 Escherichia coli species Decreases
1 0 Staphylococcus aureus species Decreases
1 0 Collinsella aerofaciens species Decreases
1 0 Clostridioides difficile species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Mediterraneibacter gnavus species Decreases
0 1 Shigella dysenteriae species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
0 1 Segatella bryantii species Decreases
1 0 Lachnospira eligens species Decreases
0 1 Escherichia fergusonii species Decreases
0 1 Leyella stercorea species Decreases
0 1 Shigella boydii species Decreases
0 1 Parolsenella catena species Decreases
0 1 Prevotella intermedia species Decreases
0 1 Shigella sonnei species Decreases
1 0 Coprococcus comes species Decreases
0 1 Leyella lascolaii species Decreases
1 0 Blautia obeum species Decreases
0 1 Escherichia marmotae species Decreases
1 0 Roseburia intestinalis species Decreases
0 1 Escherichia sp. E4742 species Decreases
0 1 Paraprevotella clara species Decreases
0 1 Prevotella bivia species Decreases
0 1 Prevotella dentalis species Decreases
1 0 Eggerthella lenta species Decreases
1 0 Thomasclavelia ramosa species Decreases
1 0 Bacteroides fragilis species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
1 0 Bifidobacterium longum species Decreases
1 0 Lacrimispora saccharolytica species Decreases
0 1 Cryptococcus neoformans species complex species group Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases

Impact of paroxetine hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.5 0 0
ADHD 1.1 0.1 10
Age-Related Macular Degeneration and Glaucoma 0.1 0.1
Allergic Rhinitis (Hay Fever) 1.4 0.7 1
Allergies 2.8 1.6 0.75
Allergy to milk products 1.3 0.3 3.33
Alopecia (Hair Loss) 0.2 0.2
Alzheimer's disease 1.4 2 -0.43
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.8 0.8 1.25
Ankylosing spondylitis 2.6 0.4 5.5
Anorexia Nervosa 0.1 0.8 -7
Antiphospholipid syndrome (APS) 0.9 0.9
Asthma 1.8 1.1 0.64
Atherosclerosis 0.9 0.3 2
Atrial fibrillation 1.3 1.7 -0.31
Autism 2.9 3.3 -0.14
Autoimmune Disease 0.4 0.1 3
benign prostatic hyperplasia 0.7 0 0
Biofilm 1.6 1.6
Bipolar Disorder 0.5 0.2 1.5
Brain Trauma 0.7 0.4 0.75
Breast Cancer 0.5 0.5
Cancer (General) 0.9 -0.9
Carcinoma 0.6 0.3 1
Celiac Disease 1 0.4 1.5
Cerebral Palsy 0.2 0.1 1
Chronic Fatigue Syndrome 1.4 1 0.4
Chronic Kidney Disease 1.3 1.2 0.08
Chronic Lyme 0.3 0.1 2
Chronic Obstructive Pulmonary Disease (COPD) 1.1 0.2 4.5
Chronic Urticaria (Hives) 0.8 1 -0.25
Coagulation / Micro clot triggering bacteria 1.4 0.1 13
Cognitive Function 0.2 0.1 1
Colorectal Cancer 1.9 1.3 0.46
Constipation 0.6 0.1 5
Coronary artery disease 2.1 0.9 1.33
COVID-19 2.9 3.4 -0.17
Crohn's Disease 2.5 1.9 0.32
Cushing's Syndrome (hypercortisolism) 0.5 0 0
cystic fibrosis 1.3 0.2 5.5
d-lactic acidosis (one form of brain fog) 1 1
deep vein thrombosis 1.7 0.1 16
Denture Wearers Oral Shifts 0.5 0.5
Depression 2.5 3.8 -0.52
Dermatomyositis 0.5 0 0
Eczema 1.5 0.1 14
Endometriosis 1.7 0.7 1.43
Epilepsy 1.4 0.6 1.33
erectile dysfunction 0.4 0 0
Fibromyalgia 0.7 0.8 -0.14
Functional constipation / chronic idiopathic constipation 1.9 1.1 0.73
gallstone disease (gsd) 1.2 0.2 5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.1 0.2 -1
Generalized anxiety disorder 1.6 0.3 4.33
Gout 0.7 0.4 0.75
Graves' disease 0.2 0.3 -0.5
Gulf War Syndrome 0.1 0.6 -5
Halitosis 0 0
Hashimoto's thyroiditis 0.4 0.3 0.33
Heart Failure 2.4 0.9 1.67
Hidradenitis Suppurativa 0.9 0.9
High Histamine/low DAO 0.8 0 0
hypercholesterolemia (High Cholesterol) 0.5 0.3 0.67
hyperglycemia 1.2 0.6 1
Hyperlipidemia (High Blood Fats) 0.4 0.2 1
hypersomnia 0.2 -0.2
hypertension (High Blood Pressure 1.5 1 0.5
Hypothyroidism 1.3 0.2 5.5
Hypoxia 0.2 0.2
IgA nephropathy (IgAN) 0.6 1.3 -1.17
Inflammatory Bowel Disease 2.8 3.7 -0.32
Insomnia 0.9 1.2 -0.33
Intelligence 0.6 0.6 0
Intracranial aneurysms 0.2 0.2 0
Irritable Bowel Syndrome 2.5 1.1 1.27
ischemic stroke 0.7 1 -0.43
Liver Cirrhosis 2.5 1.5 0.67
Long COVID 1.8 1.9 -0.06
Low bone mineral density 0.2 -0.2
Lung Cancer 0.4 0.4 0
Lymphoma 0.4 0.4
Mast Cell Issues / mastitis 1.2 0.1 11
ME/CFS with IBS 0.3 -0.3
ME/CFS without IBS 0.4 0.1 3
Menopause 0 0.2 0
Metabolic Syndrome 2.5 1.1 1.27
Mood Disorders 2.3 3.7 -0.61
multiple chemical sensitivity [MCS] 0.2 0.1 1
Multiple Sclerosis 2.5 1.7 0.47
Multiple system atrophy (MSA) 0.5 0.1 4
myasthenia gravis 0.4 0.1 3
neuropathic pain 0 0.4 0
Neuropathy (all types) 0.3 0.3 0
neuropsychiatric disorders (PANDAS, PANS) 0.5 0.5
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2 1.6 0.25
NonCeliac Gluten Sensitivity 0.6 0.1 5
Obesity 3.5 2.5 0.4
obsessive-compulsive disorder 1.6 1.9 -0.19
Osteoarthritis 1.2 0.2 5
Osteoporosis 1 0.4 1.5
pancreatic cancer 0.3 0.3
Parkinson's Disease 3.1 2.6 0.19
Polycystic ovary syndrome 1.1 0.3 2.67
Postural orthostatic tachycardia syndrome 0.1 -0.1
Premenstrual dysphoric disorder 0.3 0.3
primary biliary cholangitis 0.2 -0.2
Primary sclerosing cholangitis 0 0.6 0
Psoriasis 1.9 1.7 0.12
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 3.2 1.1 1.91
Rosacea 0.3 0.1 2
Schizophrenia 1.1 0.5 1.2
scoliosis 1.1 0.2 4.5
sensorineural hearing loss 0.5 0.5
Sjögren syndrome 1.1 0.6 0.83
Sleep Apnea 0.3 0.2 0.5
Slow gastric motility / Gastroparesis 0.5 0 0
Small Intestinal Bacterial Overgrowth (SIBO) 0.8 0 0
Stress / posttraumatic stress disorder 1.2 0.7 0.71
Systemic Lupus Erythematosus 2 0.3 5.67
Tic Disorder 1 -1
Tourette syndrome 0.2 0 0
Type 1 Diabetes 1.4 0.5 1.8
Type 2 Diabetes 3 1.9 0.58
Ulcerative colitis 1.9 1.6 0.19
Unhealthy Ageing 0.8 0.9 -0.13
Vitiligo 0.2 0.3 -0.5

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]